A Study to Learn How Safe the Study Treatment Actinium-225-macropa-pelgifatamab (BAY3546828) is, How it Affects the Body, How it Moves Into, Through and Out of the Body, and About Its Anticancer Activity in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC)
Clinical trial NCT06052306 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06052306
- Sponsor
- Bayer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-20
- Primary completion
- 2027-06-08
- Enrollment
- 232
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.